ChiCTR注册号: Reg No. in ChiCTR: |
伦审第 S2021-339-02号 | ||||||||||||||||||||||
研究题目: |
特瑞普利单抗注射液联合 AP 诱导化疗序贯同步放化疗及免疫维持治疗用于 IVb 期非转移性下咽癌疗效及安全性探索的 II 期临床研究 |
||||||||||||||||||||||
Study title: |
Efficacy and safety of Toripalimab combined with AP-induced chemotherapy followed by concurrent chemoradiotherapy and Toripalimab-maintenance therapy sequentially in patients with non-metastatic IVB hypopharyngeal cancer : A open-lable, single-arm ,phase II clinical study |
||||||||||||||||||||||
注册状况: Registration: |
True |
||||||||||||||||||||||
注册机构: |
解放军总医院第六医学中心耳鼻咽喉头颈外科学部 |
||||||||||||||||||||||
Name of the Registry: |
Department of Otolaryngology head and Neck Surgery, The Sixth Medical Center, PLA General Hospital |
||||||||||||||||||||||
项目负责人: |
张欣欣 |
||||||||||||||||||||||
Corresponding person: |
Xinxinzhang |
||||||||||||||||||||||
电话: Telephone: |
18633890128 | ||||||||||||||||||||||
电子邮件 |
gengzeyang@sina.cn |
||||||||||||||||||||||
通讯地址: |
北京市海淀区阜成路6号 |
||||||||||||||||||||||
Address: |
No.6 Fucheng Road, Haidian District, Beijing |
||||||||||||||||||||||
邮政编码 Postcode |
100000 |
||||||||||||||||||||||
项目负责人所有单位: |
解放军总医院第六医学中心耳鼻咽喉头颈外科学部 |
||||||||||||||||||||||
Institution: |
Department of Otolaryngology head and Neck Surgery |
||||||||||||||||||||||
批准本研究的伦理委员会名称: |
中国人民解放军总医院医学伦理委员会 |
||||||||||||||||||||||
Name of the ethic committee: |
Ethics Committee of Chinese PLA General Hospital |
||||||||||||||||||||||
研究疾病: |
下咽癌 | ||||||||||||||||||||||
Study Ailment: |
|||||||||||||||||||||||
研究所处阶段: Study phase: |
上市后 | ||||||||||||||||||||||
研究类型: Type of Study: |
治疗研究 | ||||||||||||||||||||||
研究实施地点: Site of Study: |
|
||||||||||||||||||||||
研究起止时间: Planned Duration: |
2021/7/1 0:00:00-2025/6/30 0:00:00 | ||||||||||||||||||||||
原研究管理平台链接网址: url of the original management platform of the trial : |
|||||||||||||||||||||||
资料文件: Data files: |
|